Nimbus Therapeutics
Updated: June 24, 2026
Founders: Ramy Farid and Bruce Booth
Country: USA | Funding: $637M (+)
Founded: 2009
Website: https://www.nimbustx.com/
Nimbus Therapeutics develops highly selective and potent small molecule drugs aimed at suppressing known factors that cause serious diseases, including metabolic diseases, cancer, and immune-inflammatory disorders (psoriasis, arthritis). The company's drug discovery platform utilizes advanced protein structure analysis, molecular modeling, machine learning-based prediction, and comprehensive data analysis within a target-oriented approach. The atomic-level data obtained using these tools enables the creation of highly accurate molecules that determine optimal pharmacological profiles for the treatment of disease pathology.
Founded: 2009
Website: https://www.nimbustx.com/
Nimbus Therapeutics develops highly selective and potent small molecule drugs aimed at suppressing known factors that cause serious diseases, including metabolic diseases, cancer, and immune-inflammatory disorders (psoriasis, arthritis). The company's drug discovery platform utilizes advanced protein structure analysis, molecular modeling, machine learning-based prediction, and comprehensive data analysis within a target-oriented approach. The atomic-level data obtained using these tools enables the creation of highly accurate molecules that determine optimal pharmacological profiles for the treatment of disease pathology.
